H19 and cancer: With a fixed-effect model, shorter DFS (pooling HR = 1.50, 95 % CI = 1.22 - 1.83, p < 0.0001) and DFS/RFS/MFS/PFS (pooling HR = 1.43, 95 % CI = 1.21 - 1.69, p = 0.004) were seen in non-female cancer patients with higher H19 expression in comparison to those with lower H19 expression (Figure 5).